Nanomix Announces Equity Investment from Senior Executive of Woodley Equipment Company, Ltd.

SAN LEANDRO, Calif, April 13, 2023 (GLOBE NEWSWIRE)

Nanomix Corporation (OTCQB: NNMX), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced an equity investment from Mike Wickham, Managing Director of Woodley Equipment Company, Ltd. Mr. Wickman purchased 59,640 shares of the Company’s common stock.

This investment marks a significant milestone for Nanomix as it continues to expand its reach and capabilities in the diagnostic industry. With the support of Mr. Wickham and Woodley Equipment Company, Ltd., Nanomix is well positioned to accelerate its growth and innovation in the POC diagnostics market.

Expanding Opportunities in Point-of-Care Diagnostics

Nanomix is at the forefront of developing cutting-edge technologies that enable rapid and accurate diagnostic testing at the point of care. By leveraging a combination of nanotechnology and biochemistry, Nanomix’s portable devices provide healthcare professionals with the tools they need to make informed treatment decisions quickly and efficiently.

The equity investment from Mr. Wickham underscores the industry’s confidence in Nanomix’s ability to revolutionize the field of diagnostic testing. With this additional funding, Nanomix can further enhance its product offerings and expand its market presence to meet the growing demand for POC diagnostics worldwide.

Impact on Individuals:

The equity investment from Woodley Equipment Company, Ltd. will potentially lead to the development of more advanced and accessible diagnostic tools for individuals. With Nanomix’s innovative technology, individuals may benefit from faster and more accurate diagnosis, leading to improved health outcomes and better quality of life.

Global Implications:

The investment from Woodley Equipment Company, Ltd. reflects the growing importance of POC diagnostics on a global scale. As Nanomix continues to advance its technology and expand its reach, the world could see a significant improvement in healthcare accessibility and efficiency. This investment sets the stage for a new era of diagnostic testing that could impact populations worldwide.

Conclusion:

The equity investment from Mike Wickham of Woodley Equipment Company, Ltd. is a testament to Nanomix’s dedication to innovation and excellence in the field of point-of-care diagnostics. With this support, Nanomix is poised to make a lasting impact on individuals and healthcare systems around the world, ushering in a new era of rapid and accurate diagnostic testing.